Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
33
SGMO Quote, Financials, Valuation and Earnings
Last price:
$0.48
Seasonality move
:
0.65%
Day range:
$0.47 - $0.49
52-week range:
$0.37 - $3.18
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.60x
P/B ratio:
24.08x
Volume:
2.3M
Avg. volume:
5.2M
1-year change:
4.72%
Market cap:
$118.1M
Revenue:
$57.8M
EPS (TTM):
-$0.39
Earnings Data
Next earnings date for SGMO
Aug 08
2025
Most recent earnings per share
-$0.14
Missed by $0.01
(May 12/2025)
Consensus Estimate
-$0.13
(May 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SGMO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $6.4M | -- | -- | -$0.13 | -- |
| 08/08/2025 | Q2 | $31.7M | -- | -- | -$0.13 | -- |
| 05/12/2025 | Q1 | $7.4M | $6.4M | -$0.14 | -$0.13 | -$0.01 |
| 03/17/2025 | Q4 | $11.7M | $7.6M | -$0.11 | -$0.05 | -$0.06 |
| 11/12/2024 | Q3 | $25.1M | $49.4M | $0.04 | -- | -- |
| 08/06/2024 | Q2 | $8.3M | $356K | -$0.18 | -$0.16 | -$0.02 |
| 05/09/2024 | Q1 | $6.4M | $481K | -$0.27 | -$0.25 | -$0.03 |
| 03/13/2024 | Q4 | $8.1M | $2M | -$0.34 | -- | -- |
| 11/01/2023 | Q3 | -- | -- | -$0.59 | -$0.29 | -$0.30 |
| 08/08/2023 | Q2 | -- | -- | -$0.66 | -$0.32 | -$0.34 |
| 04/26/2023 | Q1 | -- | -- | $0.12 | -$0.26 | $0.38 |
| 02/22/2023 | Q4 | -- | -- | -$0.32 | -$0.36 | $0.04 |
| 11/03/2022 | Q3 | -- | -- | -$0.34 | -$0.36 | $0.02 |
| 08/04/2022 | Q2 | -- | -- | -$0.29 | -$0.34 | $0.05 |
| 05/05/2022 | Q1 | -- | -- | -$0.30 | -$0.29 | -$0.01 |
| 02/24/2022 | Q4 | -- | -- | -$0.26 | -$0.34 | $0.08 |
| 11/04/2021 | Q3 | -- | -- | -$0.33 | -$0.33 | -$0.00 |
| 08/05/2021 | Q2 | -- | -- | -$0.33 | -$0.31 | -$0.02 |
| 05/04/2021 | Q1 | -- | -- | -$0.32 | -$0.29 | -$0.03 |
| 02/24/2021 | Q4 | -- | -- | -$0.29 | -$0.22 | -$0.07 |
| 11/04/2020 | Q3 | -- | -- | -$0.01 | -$0.25 | $0.24 |
| 08/05/2020 | Q2 | -- | -- | -$0.26 | -$0.34 | $0.08 |
| 05/11/2020 | Q1 | -- | -- | -$0.37 | -$0.35 | -$0.02 |
| 02/28/2020 | Q4 | -- | -- | $0.04 | -$0.33 | $0.37 |
| 11/06/2019 | Q3 | -- | -- | -$0.24 | -$0.34 | $0.10 |
| 08/07/2019 | Q2 | -- | -- | -$0.26 | -$0.35 | $0.09 |
| 05/08/2019 | Q1 | -- | -- | -$0.41 | -$0.24 | -$0.17 |
| 02/07/2019 | Q4 | -- | -- | -$0.18 | -$0.23 | $0.05 |
| 11/08/2018 | Q3 | -- | -- | -$0.13 | -$0.18 | $0.05 |
| 08/08/2018 | Q2 | -- | -- | -$0.17 | -$0.15 | -$0.02 |
| 05/08/2018 | Q1 | -- | -- | -$0.23 | -$0.18 | -$0.05 |
| 02/22/2018 | Q4 | -- | -- | -$0.15 | -$0.18 | $0.03 |
| 11/09/2017 | Q3 | -- | -- | -$0.15 | -$0.19 | $0.04 |
| 08/09/2017 | Q2 | -- | -- | -$0.17 | -$0.22 | $0.05 |
| 05/10/2017 | Q1 | -- | -- | -$0.23 | -$0.25 | $0.02 |
| 02/28/2017 | Q4 | -- | -- | -- | -- | -- |
| 10/26/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/03/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/02/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/09/2016 | Q4 | -- | -- | -- | -- | -- |
| 10/28/2015 | Q3 | -- | -- | -- | -- | -- |
Sangamo Therapeutics Earnings Questions
-
How Much did Sangamo Therapeutics Generate in Revenue Last Quarter?
Sangamo Therapeutics reported $6.4M worth of top line sales in its most recent quarter.
-
Did Sangamo Therapeutics Beat Earnings Last Quarter?
Sangamo Therapeutics announced earnings per share of -$0.14 which represents a miss of analyst forecast a -$0.13 per share.
-
Is Sangamo Therapeutics Profitable?
Sangamo Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Sangamo Therapeutics EPS Next Year?
Sangamo Therapeutics's earnings are forecast to decrease from -$0.49 per share to -$0.42 per share next year representing a decrease of -6.8%.
-
When is Sangamo Therapeutics's Earnings Date?
Sangamo Therapeutics's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
93
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
